title: Oral mucosal manifestations of chronic eosinophilic leukaemia with FIP1L1-PDGFRα.
authors.affiliation: Teikyo University Chiba Medical Center, Ichihara, Japan.
authors.forename: Kenji
authors.initials: K
authors.lastname: Tsuda
authors.affiliation: Navitas Clinic, Tachikawa, Japan.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Tanimoto
authors.affiliation: Teikyo University Chiba Medical Center, Ichihara, Japan.
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Hayakawa
authors.affiliation: Teikyo University Chiba Medical Center, Ichihara, Japan.
authors.forename: Tsunehiko
authors.initials: T
authors.lastname: Komatsu
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D000068877:Imatinib Mesylate / Q000627:therapeutic use; D007938:Leukemia; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D019226:Oral Ulcer / Q000209:etiology* / Q000473:pathology; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D015514:Oncogene Proteins, Fusion; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha